Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

por Engesæter, Birgit, Engebraaten, Olav, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Publicado 2012

Sensitization of interferon-γ induced apoptosis in human osteosarcoma cells by extracellular S100A4

por Pedersen, Kjetil Boye, Andersen, Kristin, Fodstad, Øystein, Mælandsmo, Gunhild Mari
Publicado 2004

Breast cancer patient-derived explant cultures recapitulate in vivo drug responses

por Pettersen, Solveig, Øy, Geir Frode, Egeland, Eivind Valen, Juell, Siri, Engebråten, Olav, Mælandsmo, Gunhild Mari, Prasmickaite, Lina
Publicado 2023

miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy

por Normann, Lisa Svartdal, Haugen, Mads Haugland, Aure, Miriam Ragle, Kristensen, Vessela N, Mælandsmo, Gunhild Mari, Sahlberg, Kristine Kleivi
Publicado 2022

Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer

por Karvelsson, Sigurdur Trausti, Wang, Qiong, Hilmarsdottir, Bylgja, Sigurdsson, Arnar, Moestue, Siver Andreas, Mælandsmo, Gunhild Mari, Halldorsson, Skarphedinn, Gudmundsson, Steinn, Rolfsson, Ottar
Publicado 2021

Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer

por Rud, Ane Kongsgaard, Boye, Kjetil, Fodstad, Øystein, Juell, Siri, Jørgensen, Lars H., Solberg, Steinar, Helland, Åslaug, Brustugun, Odd Terje, Mælandsmo, Gunhild Mari
Publicado 2016

Soluble AXL as a marker of disease progression and survival in melanoma

por Flem-Karlsen, Karine, Nyakas, Marta, Farstad, Inger Nina, McFadden, Erin, Wernhoff, Patrik, Jacobsen, Kari Dolven, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Publicado 2020

Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics

por Saeednejad Zanjani, Leili, Madjd, Zahra, Rasti, Arezoo, Asgari, Mojgan, Abolhasani, Maryam, Tam, Kevin J., Roudi, Raheleh, Mælandsmo, Gunhild Mari, Fodstad, Øystein, Andersson, Yvonne
Publicado 2019

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

por Normann, Lisa Svartdal, Aure, Miriam Ragle, Leivonen, Suvi-Katri, Haugen, Mads Haugland, Hongisto, Vesa, Kristensen, Vessela N., Mælandsmo, Gunhild Mari, Sahlberg, Kristine Kleivi
Publicado 2021

Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model

por Kim, Eugene, Tunset, Hanna Maja, Cebulla, Jana, Vettukattil, Riyas, Helgesen, Heidi, Feuerherm, Astrid Jullumstrø, Engebråten, Olav, Mælandsmo, Gunhild Mari, Johansen, Berit, Moestue, Siver Andreas
Publicado 2016

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

por Jernström, Sandra, Hongisto, Vesa, Leivonen, Suvi-Katri, Due, Eldri Undlien, Tadele, Dagim Shiferaw, Edgren, Henrik, Kallioniemi, Olli, Perälä, Merja, Mælandsmo, Gunhild Mari, Sahlberg, Kristine Kleivi
Publicado 2017

AXL inhibition improves BRAF-targeted treatment in melanoma

por Nyakas, Marta, Fleten, Karianne Giller, Haugen, Mads Haugland, Engedal, Nikolai, Sveen, Christina, Farstad, Inger Nina, Flørenes, Vivi Ann, Prasmickaite, Lina, Mælandsmo, Gunhild Mari, Seip, Kotryna
Publicado 2022

Low Concordance Between T-Cell Densities in Matched Primary Tumors and Liver Metastases in Microsatellite Stable Colorectal Cancer

por Dagenborg, Vegar Johansen, Marshall, Serena Elizabeth, Grzyb, Krzysztof, Fretland, Åsmund Avdem, Lund-Iversen, Marius, Mælandsmo, Gunhild Mari, Ree, Anne Hansen, Edwin, Bjørn, Yaqub, Sheraz, Flatmark, Kjersti
Publicado 2021

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer

por Normann, Lisa Svartdal, Haugen, Mads Haugland, Hongisto, Vesa, Aure, Miriam Ragle, Leivonen, Suvi-Katri, Kristensen, Vessela N., Tahiri, Andliena, Engebraaten, Olav, Sahlberg, Kristine Kleivi, Mælandsmo, Gunhild Mari
Publicado 2023

A combined experimental-computational approach uncovers a role for the Golgi matrix protein Giantin in breast cancer progression

por Ghannoum, Salim, Fantini, Damiano, Zahoor, Muhammad, Reiterer, Veronika, Phuyal, Santosh, Leoncio Netto, Waldir, Sørensen, Øystein, Iyer, Arvind, Sengupta, Debarka, Prasmickaite, Lina, Mælandsmo, Gunhild Mari, Köhn-Luque, Alvaro, Farhan, Hesso
Publicado 2023

Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide

por Øverbye, Anders, Holsæter, Ann Mari, Markus, Fusser, Škalko-Basnet, Nataša, Iversen, Tore-Geir, Torgersen, Maria Lyngaas, Sønstevold, Tonje, Engebraaten, Olav, Flatmark, Kjersti, Mælandsmo, Gunhild Mari, Skotland, Tore, Sandvig, Kirsten
Publicado 2017

The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers

por Knutsen, Erik, Lellahi, Seyed Mohammad, Aure, Miriam Ragle, Nord, Silje, Fismen, Silje, Larsen, Kenneth Bowitz, Gabriel, Marta Tellez, Hedberg, Annica, Bjørklund, Sunniva Stordal, Bofin, Anna Mary, Mælandsmo, Gunhild Mari, Sørlie, Therese, Mortensen, Elin Synnøve, Perander, Maria
Publicado 2020

Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases

por Østrup, Olga, Dagenborg, Vegar Johansen, Rødland, Einar Andreas, Skarpeteig, Veronica, Silwal-Pandit, Laxmi, Grzyb, Krzysztof, Berstad, Audun Elnæs, Fretland, Åsmund Avdem, Mælandsmo, Gunhild Mari, Børresen-Dale, Anne-Lise, Ree, Anne Hansen, Edwin, Bjørn, Nygaard, Vigdis, Flatmark, Kjersti
Publicado 2017

Liver X receptors induce antiproliferative effects in basal‐like breast cancer

por Haugen, Mads Haugland, von der Lippe Gythfeldt, Hedda, Egeland, Eivind Valen, Svartdal Normann, Lisa, Pandya, Abhilash D., Vedin, Lise‐Lotte, Juell, Siri, Tenstad, Ellen, Øy, Geir Frode, Kristian, Alexandr, Marangoni, Elisabetta, Sørlie, Therese, Steffensen, Knut, Mælandsmo, Gunhild Mari, Engebraaten, Olav
Publicado 2023

Low β(2)-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism

por Braadland, Peder Rustøen, Grytli, Helene Hartvedt, Ramberg, Håkon, Katz, Betina, Kellman, Ralf, Gauthier-Landry, Louis, Fazli, Ladan, Krobert, Kurt Allen, Wang, Wanzhong, Levy, Finn Olav, Bjartell, Anders, Berge, Viktor, Rennie, Paul S., Mellgren, Gunnar, Mælandsmo, Gunhild Mari, Svindland, Aud, Barbier, Olivier, Taskén, Kristin Austlid
Publicado 2015